Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001178913-15-000942

President and CEO bought 2,600 shares at an average $3.88 ($10,082)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KIDRON NADAV President and CEO 2015-03-18 Purchase +500 $3.78 $1,890 954,448 D: show line 1 in the form
KIDRON NADAV President and CEO 2015-03-18 Purchase +500 $3.80 $1,900 954,948 D: show line 2 in the form
KIDRON NADAV President and CEO 2015-03-19 Purchase +400 $3.95 $1,580 955,348 D: show line 3 in the form
KIDRON NADAV President and CEO 2015-03-19 Purchase +1,100 $3.92 $4,312 956,448 D: show line 4 in the form
KIDRON NADAV President and CEO 2015-03-19 Purchase +100 $4.00 $400 956,548 D: show line 5 in the form
Open-market purchases · 2,600 sh · avg $3.88 · $10,082
Loading xslF345X03/zk1516648.xml…